CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog
Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
Frontiers | Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
CD47 — Wikipédia
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
CD47: the next checkpoint target for cancer immunotherapy - ScienceDirect
CD47‐signal regulatory protein α signaling system and its application to cancer immunotherapy - Murata - 2018 - Cancer Science - Wiley Online Library
CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes | American Journal of Physiology-Cell Physiology
Anticorps CD47 (BRIC 126) | SCBT - Santa Cruz Biotechnology
CD47 - an overview | ScienceDirect Topics
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma | Haematologica
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions | bioRxiv
CD47 | Majeti Lab | Stanford Medicine
JCI - Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
Targeting CD47 for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
Leukocyte Surface Antigen CD47 - ACROBiosystems
063CE: Anti-CD47 Testing Interference with Connie Westhoff -
Vaccines | Free Full-Text | Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New Immunotherapies | The Stem Cellar
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy: Trends in Immunology
Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis: Molecular Therapy - Oncolytics
A) CD47-SIRPɑ interaction blocks macrophage phagocytosis of cancer... | Download Scientific Diagram
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
